Bluejay Diagnostics announces 1 for 50 reverse stock split

Bluejay Diagnostics ( NASDAQ: BJDX ) announced that the company’s Board has approved a reverse stock split of its shares of common stock at a ratio of 1-for-50. The Reverse Stock Split will become effective at 12:01 a.m.

ET on November 18, 2024, and the company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis on November 18, 2024 under the Company’s existing trading symbol, “BJDX.” Source: Press Release More on Bluejay Diagnostics Financial information for Bluejay Diagnostics.